Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.

Identifieur interne : 000283 ( PubMed/Checkpoint ); précédent : 000282; suivant : 000284

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.

Auteurs : Kuldeep Dhama [Inde] ; Khan Sharun [Inde] ; Ruchi Tiwari [Inde] ; Maryam Dadar [Iran] ; Yashpal Singh Malik [Inde] ; Karam Pal Singh [Inde] ; Wanpen Chaicumpa [Thaïlande]

Source :

RBID : pubmed:32186952

Abstract

The novel coronavirus infection (COVID-19 or Coronavirus disease 2019) that emerged from Wuhan, Hubei province of China has spread to many countries worldwide. Efforts have been made to develop vaccines against human coronavirus (CoV) infections such as MERS and SARS in the past decades. However, to date, no licensed antiviral treatment or vaccine exists for MERS and SARS. Most of the efforts for developing CoV vaccines and drugs target the spike glycoprotein or S protein, the major inducer of neutralizing antibodies. Although a few candidates have shown efficacy in in vitro studies, not many have progressed to randomized animal or human trials, hence may have limited use to counter COVID-19 infection. This article highlights ongoing advances in designing vaccines and therapeutics to counter COVID-19 while also focusing on such experiences and advances as made with earlier SARS- and MERS-CoVs, which together could enable efforts to halt this emerging virus infection.

DOI: 10.1080/21645515.2020.1735227
PubMed: 32186952


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32186952

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.</title>
<author>
<name sortKey="Dhama, Kuldeep" sort="Dhama, Kuldeep" uniqKey="Dhama K" first="Kuldeep" last="Dhama">Kuldeep Dhama</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly</wicri:regionArea>
<wicri:noRegion>Bareilly</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sharun, Khan" sort="Sharun, Khan" uniqKey="Sharun K" first="Khan" last="Sharun">Khan Sharun</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly</wicri:regionArea>
<wicri:noRegion>Bareilly</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tiwari, Ruchi" sort="Tiwari, Ruchi" uniqKey="Tiwari R" first="Ruchi" last="Tiwari">Ruchi Tiwari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU), Mathura, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU), Mathura</wicri:regionArea>
<wicri:noRegion>Mathura</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Dadar, Maryam" sort="Dadar, Maryam" uniqKey="Dadar M" first="Maryam" last="Dadar">Maryam Dadar</name>
<affiliation wicri:level="1">
<nlm:affiliation>Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj</wicri:regionArea>
<wicri:noRegion>Karaj</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Malik, Yashpal Singh" sort="Malik, Yashpal Singh" uniqKey="Malik Y" first="Yashpal Singh" last="Malik">Yashpal Singh Malik</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biological Standardization, ICAR-Indian Veterinary Research Institute, Bareilly, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Division of Biological Standardization, ICAR-Indian Veterinary Research Institute, Bareilly</wicri:regionArea>
<wicri:noRegion>Bareilly</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Singh, Karam Pal" sort="Singh, Karam Pal" uniqKey="Singh K" first="Karam Pal" last="Singh">Karam Pal Singh</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly</wicri:regionArea>
<wicri:noRegion>Bareilly</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chaicumpa, Wanpen" sort="Chaicumpa, Wanpen" uniqKey="Chaicumpa W" first="Wanpen" last="Chaicumpa">Wanpen Chaicumpa</name>
<affiliation wicri:level="1">
<nlm:affiliation>Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32186952</idno>
<idno type="pmid">32186952</idno>
<idno type="doi">10.1080/21645515.2020.1735227</idno>
<idno type="wicri:Area/PubMed/Corpus">000150</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000150</idno>
<idno type="wicri:Area/PubMed/Curation">000150</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000150</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000283</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000283</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.</title>
<author>
<name sortKey="Dhama, Kuldeep" sort="Dhama, Kuldeep" uniqKey="Dhama K" first="Kuldeep" last="Dhama">Kuldeep Dhama</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly</wicri:regionArea>
<wicri:noRegion>Bareilly</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Sharun, Khan" sort="Sharun, Khan" uniqKey="Sharun K" first="Khan" last="Sharun">Khan Sharun</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly</wicri:regionArea>
<wicri:noRegion>Bareilly</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tiwari, Ruchi" sort="Tiwari, Ruchi" uniqKey="Tiwari R" first="Ruchi" last="Tiwari">Ruchi Tiwari</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU), Mathura, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU), Mathura</wicri:regionArea>
<wicri:noRegion>Mathura</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Dadar, Maryam" sort="Dadar, Maryam" uniqKey="Dadar M" first="Maryam" last="Dadar">Maryam Dadar</name>
<affiliation wicri:level="1">
<nlm:affiliation>Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj</wicri:regionArea>
<wicri:noRegion>Karaj</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Malik, Yashpal Singh" sort="Malik, Yashpal Singh" uniqKey="Malik Y" first="Yashpal Singh" last="Malik">Yashpal Singh Malik</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biological Standardization, ICAR-Indian Veterinary Research Institute, Bareilly, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Division of Biological Standardization, ICAR-Indian Veterinary Research Institute, Bareilly</wicri:regionArea>
<wicri:noRegion>Bareilly</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Singh, Karam Pal" sort="Singh, Karam Pal" uniqKey="Singh K" first="Karam Pal" last="Singh">Karam Pal Singh</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly</wicri:regionArea>
<wicri:noRegion>Bareilly</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chaicumpa, Wanpen" sort="Chaicumpa, Wanpen" uniqKey="Chaicumpa W" first="Wanpen" last="Chaicumpa">Wanpen Chaicumpa</name>
<affiliation wicri:level="1">
<nlm:affiliation>Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Human vaccines & immunotherapeutics</title>
<idno type="eISSN">2164-554X</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The novel coronavirus infection (COVID-19 or Coronavirus disease 2019) that emerged from Wuhan, Hubei province of China has spread to many countries worldwide. Efforts have been made to develop vaccines against human coronavirus (CoV) infections such as MERS and SARS in the past decades. However, to date, no licensed antiviral treatment or vaccine exists for MERS and SARS. Most of the efforts for developing CoV vaccines and drugs target the spike glycoprotein or S protein, the major inducer of neutralizing antibodies. Although a few candidates have shown efficacy in
<i>in vitro</i>
studies, not many have progressed to randomized animal or human trials, hence may have limited use to counter COVID-19 infection. This article highlights ongoing advances in designing vaccines and therapeutics to counter COVID-19 while also focusing on such experiences and advances as made with earlier SARS- and MERS-CoVs, which together could enable efforts to halt this emerging virus infection.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">32186952</PMID>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2164-554X</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2020</Year>
<Month>Mar</Month>
<Day>18</Day>
</PubDate>
</JournalIssue>
<Title>Human vaccines & immunotherapeutics</Title>
<ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
</Journal>
<ArticleTitle>COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.</ArticleTitle>
<Pagination>
<MedlinePgn>1-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2020.1735227</ELocationID>
<Abstract>
<AbstractText>The novel coronavirus infection (COVID-19 or Coronavirus disease 2019) that emerged from Wuhan, Hubei province of China has spread to many countries worldwide. Efforts have been made to develop vaccines against human coronavirus (CoV) infections such as MERS and SARS in the past decades. However, to date, no licensed antiviral treatment or vaccine exists for MERS and SARS. Most of the efforts for developing CoV vaccines and drugs target the spike glycoprotein or S protein, the major inducer of neutralizing antibodies. Although a few candidates have shown efficacy in
<i>in vitro</i>
studies, not many have progressed to randomized animal or human trials, hence may have limited use to counter COVID-19 infection. This article highlights ongoing advances in designing vaccines and therapeutics to counter COVID-19 while also focusing on such experiences and advances as made with earlier SARS- and MERS-CoVs, which together could enable efforts to halt this emerging virus infection.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dhama</LastName>
<ForeName>Kuldeep</ForeName>
<Initials>K</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0001-7469-4752</Identifier>
<AffiliationInfo>
<Affiliation>Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sharun</LastName>
<ForeName>Khan</ForeName>
<Initials>K</Initials>
<Identifier Source="ORCID">https://orcid.org/0000-0003-1040-3746</Identifier>
<AffiliationInfo>
<Affiliation>Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tiwari</LastName>
<ForeName>Ruchi</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU), Mathura, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dadar</LastName>
<ForeName>Maryam</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malik</LastName>
<ForeName>Yashpal Singh</ForeName>
<Initials>YS</Initials>
<AffiliationInfo>
<Affiliation>Division of Biological Standardization, ICAR-Indian Veterinary Research Institute, Bareilly, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Karam Pal</ForeName>
<Initials>KP</Initials>
<AffiliationInfo>
<Affiliation>Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chaicumpa</LastName>
<ForeName>Wanpen</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>03</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hum Vaccin Immunother</MedlineTA>
<NlmUniqueID>101572652</NlmUniqueID>
<ISSNLinking>2164-5515</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Emerging coronavirus</Keyword>
<Keyword MajorTopicYN="N">drugs</Keyword>
<Keyword MajorTopicYN="N">therapeutics</Keyword>
<Keyword MajorTopicYN="N">vaccines</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>3</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>3</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>3</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32186952</ArticleId>
<ArticleId IdType="doi">10.1080/21645515.2020.1735227</ArticleId>
<ArticleId IdType="pmc">PMC7103671</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2015 Dec 07;10(12):e0144475</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26641892</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2018 Jan 17;92(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29142129</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Pathog. 2014 Aug 21;10(8):e1004250</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25144235</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Microbiol. 2013 Dec;11(12):836-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24217413</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Expert Rev Vaccines. 2018 Aug;17(8):677-686</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30058403</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2020 Jan;577(7792):607</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31992886</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2004 Oct;78(19):10628-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15367630</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2005 Jul;11(7):1016-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16022774</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2013 Jul;87(14):8017-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23678171</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Front Microbiol. 2017 Aug 03;8:1469</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28824594</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect. 2005 Oct;51(3):263-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16045996</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):470-473</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31986257</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2020 Dec;9(1):275-277</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32005086</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2008 Apr;133(1):20-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17499378</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Front Immunol. 2018 Aug 10;9:1803</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30147687</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2019;8(1):516-530</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30938227</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2019 Jul 22;14(7):e0220196</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31329652</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2015 Dec 15;212(12):1904-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26198719</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 05;43(0):E002</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32023685</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Drug Discov. 2016 May;15(5):327-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26868298</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Virol. 2020 Apr;92(4):433-440</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31967321</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Microbiol. 2009 Mar;7(3):226-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19198616</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2013 Oct;19(10):1313-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24013700</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trials. 2018 Jan 30;19(1):81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29382391</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Microbes Infect. 2013 Jul-Aug;15(8-9):625-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23791956</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biosci Trends. 2020 Mar 16;14(1):69-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31996494</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Thorax. 2004 Mar;59(3):252-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14985565</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2014 Jan;101:105-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24269477</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15210961</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vet Q. 2020 Dec;40(1):68-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32036774</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2004 Jun;78(12):6134-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15163706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2018 Mar 21;7(1):41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29568066</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Expert Rev Vaccines. 2016 Sep;15(9):1123-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26985862</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Methods Mol Biol. 2020;2099:137-159</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31883094</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2020 Jan 15;276:197834</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31816342</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Microbes Infect. 2020 Mar;22(2):74-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32017984</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 16;43(0):E014</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32061198</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2018 Aug 16;92(17):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29976657</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2013 Apr 18;368(16):1560-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23550601</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Viruses. 2020 Jan 20;12(1):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31968702</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Drug Discov. 2020 Mar;19(3):149-150</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32127666</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2020 Jan 31;367(6477):492-493</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32001631</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Virol. 2006 Dec;78(12):1509-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17063504</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2005 Jan 4;23(7):924-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15603894</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Front Microbiol. 2019 Aug 02;10:1781</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31428074</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Microbiol. 2016 Nov 28;2:16226</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27892925</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4970-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24599590</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Expert Opin Ther Pat. 2013 Oct;23(10):1337-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23905913</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Chembiochem. 2020 Mar 2;21(5):730-738</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32022370</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Commun. 2020 Jan 10;11(1):222</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31924756</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2017 Jan;137:82-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27840203</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Adv Virus Res. 2016;96:245-286</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27712626</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2019;8(1):841-856</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31169078</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Feb;20(2):276-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24457147</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2006 Apr;80(8):4079-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16571824</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Drug Discov Today. 2020 Jan 30;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32006468</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Acta Pharm. 2020 Jun 1;70(2):145-159</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31955138</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2003 Oct 30;425(6961):915</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14586458</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>IEEE/ACM Trans Comput Biol Bioinform. 2018 Jul-Aug;15(4):1344-1350</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28574363</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Opin Virol. 2015 Aug;13:123-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26184451</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci China Life Sci. 2017 Dec;60(12):1399-1402</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29134417</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2020 Mar;278:197863</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31945421</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Virol. 2020 May;92(5):495-500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32022276</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2008 Aug;82(15):7721-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18463152</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2004 Apr 1;428(6982):561-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15024391</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2006 Nov 30;24(49-50):7056-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16930781</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Virol. 2020 May;92(5):479-490</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32052466</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Comp Med. 2007 Oct;57(5):450-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17974127</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vet Q. 2019 Dec;39(1):26-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31006350</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Hosp Infect. 2020 Mar;104(3):254-255</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31962139</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Inde</li>
<li>Iran</li>
<li>Thaïlande</li>
</country>
</list>
<tree>
<country name="Inde">
<noRegion>
<name sortKey="Dhama, Kuldeep" sort="Dhama, Kuldeep" uniqKey="Dhama K" first="Kuldeep" last="Dhama">Kuldeep Dhama</name>
</noRegion>
<name sortKey="Malik, Yashpal Singh" sort="Malik, Yashpal Singh" uniqKey="Malik Y" first="Yashpal Singh" last="Malik">Yashpal Singh Malik</name>
<name sortKey="Sharun, Khan" sort="Sharun, Khan" uniqKey="Sharun K" first="Khan" last="Sharun">Khan Sharun</name>
<name sortKey="Singh, Karam Pal" sort="Singh, Karam Pal" uniqKey="Singh K" first="Karam Pal" last="Singh">Karam Pal Singh</name>
<name sortKey="Tiwari, Ruchi" sort="Tiwari, Ruchi" uniqKey="Tiwari R" first="Ruchi" last="Tiwari">Ruchi Tiwari</name>
</country>
<country name="Iran">
<noRegion>
<name sortKey="Dadar, Maryam" sort="Dadar, Maryam" uniqKey="Dadar M" first="Maryam" last="Dadar">Maryam Dadar</name>
</noRegion>
</country>
<country name="Thaïlande">
<noRegion>
<name sortKey="Chaicumpa, Wanpen" sort="Chaicumpa, Wanpen" uniqKey="Chaicumpa W" first="Wanpen" last="Chaicumpa">Wanpen Chaicumpa</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000283 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000283 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:32186952
   |texte=   COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:32186952" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021